-
2025 – RWC Update: Oral Therapy Options for Diabetic Retinopathy; High-Definition Peeling; Laser Maculopathy With Acute Sub-ILM Hemorrhage
-
2025 – Preventive and Protective Effects of Nicotinamide Adenine Dinucleotide Boosters in Aging and Retinal Diseases
-
2025 – Mechanisms Underlying Myopia Progression from Visual Signaling to Metabolic Remodeling in Retina
-
2025 – Diabetic Retinopathy: A Comprehensive Overview on Pathophysiology and Relevant Experimental Models
-
2025 – Editorial: Ischemic Retinopathy: Underlying Pathologic Mechanisms and Identifying Therapeutic Molecular Targets
-
2025 – Impact of Extended Lens-Induced Myopia on Retinal Structure and Function in Mice
-
2025 – Digital Health as a Scalable Strategy for Equitable Myopia Management in East Asia
-
2025 – Combined Dietary Omega-3 and Omega-6 Fatty Acids Protect Against Hyperglycemia-Associated Retinopathy
-
2025 – Antibiotics-Induced Gut Microbiome Dysbiosis Affects Susceptibility to Minus Lens-Induced Myopia
-
2025 – Assessing Public Awareness of Myopia After the COVID-19 Pandemic
-
2025 – Unilateral Common Carotid Artery Occlusion With Streptozotocin Leads to Early Retinal Inflammation
-
2025 – Novel Therapeutic Approaches for Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration
-
2025 – Nutrient Supplementation Mitigates Retinal Dysfunction in Acox1 Knockout Mice
-
2025 – Folic Acid Supplementation Inhibits Proliferative Retinopathy of Prematurity
-
2024 – Therapeutic Effects of Taurine and Histidine Supplementation in Retinal Diseases
-
2024 – Recent Insights Into Roles of Hypoxia-Inducible Factors in Retinal Diseases
-
2024 – Establishment of an In Vitro Choroid Complex System for Vascular Response Screening
-
2024 – Inhibition of Hypoxia-Inducible Factors Suppresses Subretinal Fibrosis
-
2024 – Myopia Is an Ischemic Eye Condition: A Review From the Perspective of Choroidal Blood Flow
-
2024 – Therapeutic Effects of Anti-Inflammatory and Anti-Oxidant Nutritional Supplementation in Retinal Ischemic Diseases
-
2024 – Retinal Ischemic Diseases and Promising Therapeutic Molecular Targets
-
2024 – Halofuginone Prevents Outer Retinal Degeneration in a Mouse Model of Light-Induced Retinopathy
-
2023 – Modulation of Hypoxia-Inducible Factors and VEGF by Camu-Camu Treatment
-
2023 – Topical Application of Bunazosin Hydrochloride Suppresses Myopia Progression
-
2023 – Opsin 5 Mediates Violet Light-Induced Early Growth Response-1 Expression
-
2023 – Highly Sensitive Visual Restoration via Ectopic Expression of Chimeric Rhodopsin
-
2023 – Fruiting Liquid of Mushroom-Forming Fungi as a Source of HIF and Axl Inhibitors
-
2023 – Nicotinamide Mononucleotide: A Potential Future Treatment in Ocular Diseases
-
2023 – Starburst Amacrine Cells Amplify Optogenetic Visual Restoration
-
2023 – Suppressive Effects of Violet Light Transmission on Myopia Progression
-
2023 – Pemafibrate Prevents Choroidal Neovascularization in AMD
-
2022 – Pemafibrate, a Promising Novel Treatment for Ischemic Retinopathy
-
2022 – Axl and HIF Inhibitors From Lepista luscina
-
2022 – Nicotinamide Mononucleotide Protects Against Retinal Dysfunction in Carotid Artery Occlusion
-
2022 – Therapeutic Roles of PPARα Activation in Ocular Ischemic Diseases
-
2022 – Nicotinamide Mononucleotide Prevents Retinal Dysfunction in Ischemia-Reperfusion Injury
-
2022 – Scleral PERK and ATF6 as Targets of Myopic Axial Elongation
-
2022 – Retinal Degeneration Induced by Ischemia-Reperfusion Injury and Its Management by Pemafibrate
-
2022 – Ocular Ischemic Syndrome and Related Experimental Models
-
2022 – Degeneration of Retinal Ganglion Cells in Hypoxic Responses
-
2021 – Retinal Degeneration in a Murine Model of Carotid Artery Occlusion
-
2021 – Retinal Diseases Regulated by Hypoxia: Basic and Clinical Perspectives
-
2021 – PPARα Modulation-Based Therapy in Central Nervous System Diseases
-
2021 – Updates on Current Treatments for Diabetic Retinopathy and Future Oral Therapy
-
2021 – Pemafibrate Prevents Retinal Dysfunction in Carotid Artery Occlusion
-
2021 – Glucose Levels in the Eye Correlate With Blood Glucose Dynamics
-
2021 – Inhibition of the HIF-1α/BNIP3 Pathway Has a Retinal Neuroprotective Effect
-
2021 – Retinal Dysfunction in a Mouse Model of Unilateral Carotid Artery Occlusion
-
2021 – HIF Inhibition Therapy in Ocular Diseases
-
2021 – Fenofibrate Protects Against Retinal Dysfunction in Ocular Ischemia
-
2020 – Rice Bran and Vitamin B6 Suppress Pathological Neovascularization
-
2020 – A Murine Model of Ischemic Retinal Injury by Bilateral Carotid Artery Occlusion
-
2020 – PPARα Agonist Oral Therapy in Diabetic Retinopathy
-
2020 – A Fairy Chemical Suppresses Retinal Angiogenesis as a HIF Inhibitor
-
2020 – Retinal Hypoperfusion Injury Induced by Carotid Artery Occlusion
-
2020 – Pemafibrate Protects Against Retinal Dysfunction in Diabetic Retinopathy
-
2020 – Prevalence of Toxocariasis and Risk Factors in Korea
-
2018 – Hepatocyte Growth Factor Promotes Peripheral Nerve Regeneration
-
2017 – Neuroprotective Effects of an Erythropoietin-Derived Peptide in Ischemic Brain Damage
